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Exposure to bacterial superantigens such as staphylococcal enterotoxin B (SEB) leads to the induction of
toxic shock syndrome which results in multiorgan failure, including liver damage. In the present study, we
investigated the role of CD44 in SEB-induced liver injury. Injection of SEB into D-galactosamine-sensitized
CD44 wild-type (WT) mice led to a significant increase in CD44 expression on liver T cells, NK cells, and NKT
cells. Administration of SEB to CD44 knockout (KO) mice caused significantly enhanced liver damage which
correlated with elevated numbers of T cells, NK cells, NKT cells, and macrophages in the liver and increased
production of tumor necrosis factor alpha and gamma interferon compared to CD44 WT mice. Furthermore,
liver mononuclear cells from CD44 KO mice were resistant to SEB-induced apoptosis, and cDNA microarray
analysis revealed that SEB activation of such cells led to the induction of several antiapoptotic genes and
repression of proapoptotic genes. Examination of CD44 isoforms revealed that SEB exposure altered CD44
variant 7 (v7) isoform expression. Interestingly, mice bearing a specific deletion of the CD44v7 exon exhibited
increased susceptibility to SEB-induced hepatitis. Finally, treatment of CD44 WT mice with anti-CD44 mono-
clonal antibodies reduced expression of CD44 in liver mononuclear cells and caused increased susceptibility
to SEB-induced liver injury. Together, these data demonstrate that the expression of CD44 and/or CD44v7 on
SEB-activated liver mononuclear cells facilitates their rapid apoptosis, thereby preventing severe liver injury
in wild-type mice, and suggest that CD44 plays an important role in the regulation and elimination of immune
cells in the liver.
Toxic shock syndrome (TSS) can result from exposure to
bacterial superantigens produced by Staphylococcus aureus and
is characterized by acute onset of illness which leads to fever,
rash formation, multiorgan failure, hepatitis, and possible le-
thal shock (34). A number of forms of TSS have been associ-
ated with staphylococcal enterotoxin B (SEB) exposure. These
include postsurgical TSS, influenza-associated TSS, recalci-
trant erythematous desquamating syndrome, and TSS with the
use of contraceptive diaphragms (34). In addition, SEB has
been listed as an agent that could be used in bioterrorism (32).
SEB is referred to as a superantigen because of its profound
effects on the immune system. Very small concentrations of
SEB can activate the immune response due to its high-avidity
binding to specific V domains of the T-cell receptor (10).
CD44 is a widely distributed surface glycoprotein expressed
by a number of lymphoid and nonlymphoid cells (8, 21). The
principal ligand of CD44 is believed to be hyaluronic acid.
CD44 is known to play important roles in a number of immu-
nological processes such as lymphocyte migration, extravasa-
tion, activation, and cytolytic activity (2, 6, 13, 14, 20, 23, 42,
45). In addition, recent evidence suggests that CD44 may also
be involved in the induction of apoptosis and activation-in-
duced cell death (AICD) (35). The exact role that CD44 plays
in apoptosis remains unclear. A number of reports suggested
that the signaling through CD44 can protect a cell from apo-
ptosis (12, 55). For example, in mice lacking the CD44v7 exon,
treatment with 2,4,6-trinitrobenzene sulfonic acid (TNBS) re-
sulted in a reduced severity of colitis due to increased apopto-
sis of lamina propria mononuclear cells (55). However, other
reports suggested that upregulation and signaling through
CD44 can lead to enhanced apoptosis (11, 19, 35). For exam-
ple, ligation of CD44 leads to apoptosis in fibroblast as well as
certain lymphocyte populations (11, 19). Recent evidence from
our laboratory demonstrated that CD44 knockout (KO) mice
show increased susceptibility to concanavalin A-induced hep-
atitis, which directly correlated with a decreased incidence of
lymphocyte apoptosis (1). It should be noted that in the TNBS
model, those authors examined the role of a specific CD44
isoform (CD44v7), while in the later experiments, the investi-
gators used monoclonal antibodies (MAbs) that recognized all
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forms of CD44 including the standard form and all isoforms or
they used mice that lacked expression of any CD44 gene prod-
ucts. Although the product of a single gene, CD44 is expressed
as multiple isoforms that result from alternatively spliced
mRNA species and posttranslational modifications (3, 17, 52).
These isoforms are expressed during different stages of activa-
tion and by different effector cells (44). Therefore, it is possible
that different CD44 isoforms may have unique and sometimes
opposite roles in the regulation of apoptosis. In fact, there is
evidence that suggests that the individual CD44 isoforms may
play specific roles in the regulation of the immune response (9,
16, 27, 48). For example, it has been demonstrated that specific
isoforms are expressed only on activated lymphocytes and that
antibodies directed against specific CD44 isoforms are able to
prevent the development of TNBS-induced colitis (55).
In addition to its clinical importance, SEB stimulation has
been used as a model for studying in vivo cytokine regulation,
T-cell anergy, and activation-induced cell death (18, 38, 40).
The liver is thought to be an important site for regulation of
the immune response. A number of reports have demonstrated
that following activation, there is a significant accumulation of
apoptotic lymphocytes in the liver (5). Recent studies from our
laboratory demonstrated a specific role for CD44 in activation-
induced cell death and therefore suggested that CD44 may also
regulate activation of T cells by superantigens (35). More spe-
cifically, primary as well as secondary responses to staphylo-
coccal enterotoxin A were elevated in CD44-deficient mice
(35). These elevated responses were due to a decrease in the
susceptibility of CD44-deficient lymphocytes to AICD. How-
ever, very little is known about the possible role of CD44 and
specific CD44 isoforms in the regulation of the immune re-
sponse in the liver microenvironment. In the present study, we
demonstrate a direct role of CD44 and the CD44v7 isoform in
the regulation of the immune response in the liver by using the
SEB model of hepatitis.
MATERIALS AND METHODS
Mice. Adult female C57BL/6 (CD44 wild type [WT]) mice were purchased
from the National Institutes of Health (Bethesda, Md.). CD44 KO mice were
kindly provided by the AMGEN Institute (Toronto, Ontario, Canada) and bred
in our animal facilities and screened for the CD44 mutation. CD44v7 KO mice
are those with a targeted deletion of CD44v7 exon products. Such mice, there-
fore, fail to express CD44 isoforms bearing the variant exon v7 (55). All these
strains were on a C57BL/6 background. The CD44 KO and CD44v7 KO mice
were bred in the animal facilities at the Virginia Commonwealth University
Medical Center and screened for the CD44 and CD44v7 deletions, respectively.
SEB-induced hepatitis and its evaluation. To induce hepatitis, female CD44
WT, CD44 KO, and CD44v7 KO mice weighing 20 to 23 g were challenged with
SEB (20 g/mouse) admixed with D-galactosamine (20 mg/mouse). Since mice
are resistant to the effects of bacterial toxins such as SEB, we increased their
sensitivity throughout this study by treatment with D-galactosamine (37). Control
mice received 100 l of saline (intravenously). Plasma from individual mice was
separated from blood obtained through the orbital plexus of the animal under
anesthesia with IsoFlo (Abbott Laboratories, North Chicago, Ill.) at various time
intervals after SEB injection. Aspartate aminotransferase activity (AST) levels in
plasma were measured by using a commercial kit (Sigma Chemical, St. Louis,
Mo.) as described previously (1).
For histopathological studies, the harvested livers were fixed in 10% buffered
formalin and embedded in paraffin. Five-micrometer sections were affixed to
slides, deparaffinized, and stained with hematoxylin and eosin to assess morpho-
logical changes as described previously (16). TUNEL (terminal deoxynucleoti-
dyltransferase-mediated dUTP-biotin nick end labeling) assay was performed by
using an ApopTag peroxidase in situ apoptosis detection kit (Serologicals Corp.,
Norcross, Ga.).
Isolation of lymphocytes infiltrating the liver. The isolation of liver-infiltrating
mononuclear cells was carried out as described previously by others (18, 19).
Briefly, livers obtained after SEB injection from CD44 WT and CD44 KO mice
were homogenized with a laboratory homogenizer (Stomacher; Tekmar, Cincin-
nati, Ohio) and suspended in RPMI medium supplemented with 5% fetal calf
serum. After one washing with the medium, the cells were resuspended in 30 ml
of medium, and infiltrating lymphocytes were separated from parenchymal hepa-
tocytes and Kupffer cells by Ficoll-Isopaque density (1.09) gradient centrifuga-
tion. The cell suspension (35 ml) was overlaid onto 15 ml of Ficoll-Isopaque in
a 50-ml conical plastic tube. Centrifugation was performed at 600  g for 30 min
at room temperature. After centrifugation, 10 ml of the interface was aspirated
and mixed with 20 ml of the medium in a 50-ml conical tube, and the cells were
washed twice.
Evaluation of induction of apoptosis. Apoptosis was measured by using both
the annexin-propidium iodide (PI) and TUNEL methods (24, 53). To detect
apoptosis with the TUNEL method, the cells were washed twice with phosphate-
buffered saline (PBS) and fixed with 4% p-formaldehyde for 30 min at room
temperature. The cells were next washed with PBS, permeabilized on ice for 2
min, and incubated with fluorescein isothiocyanate (FITC)-dUTP and terminal
deoxynucleotidyl transferase (TdT) (Boehringer Mannheim, Indianapolis, Ind.)
for 1 h at 37°C and 5% CO2 (24). To detect apoptosis with the annexin V-PI
method, the cells were washed twice with PBS and stained with annexin V and
PI for 20 min at room temperature (53). The cells were washed twice with PBS.
The levels of apoptosis in both the TUNEL and annexin-PI assays were deter-
mined by measuring the fluorescence of the cells by flow cytometric analysis. Five
thousand cells were analyzed per sample.
Analysis of cell surface markers. Twenty-four hours following exposure to
SEB and D-galactosamine, the liver mononuclear cells were screened for various
cell surface markers by using flow cytometry. Briefly, 106 mononuclear cells were
incubated with Fc receptor block (Pharmingen, San Diego, Calif.) followed by
culture with phycoerythrin (PE)- or FITC-conjugated anti-mouse CD3, anti-
mouse CD8, anti-mouse CD4, anti-mouse Mac-3 (macrophages), anti-NK1.1
(NK cells), or anti-CD19 MAb (B cells) (Pharmingen) on ice for 30 min. The
cells were washed with PBS three times and analyzed for fluorescence by using
a flow cytometer (11).
Analysis of protein expression by Western blot analysis. Protein was isolated
from liver mononuclear cells from mice injected with PBS or SEB by freeze-
thawing, and the protein concentration was determined by using a bicinchoninic
acid protein assay kit (Pierce, Rockford, Ill.). The protein (15 g) was run on a
7.5% acrylamide gel. The protein was transferred to a nitrocellulose membrane.
Nonspecific binding was blocked by incubating the membrane in 5% blotting-
grade blocker nonfat dry milk (Bio-Rad, Hercules, Calif.) for 1 h at room
temperature. The membrane was rinsed and then washed three times for 10 min
with Tris-buffered saline containing 0.1% Tween 20. The membrane was then
probed with the specific primary antibody in 5% blocking solution overnight at
4°C. The membrane was then rinsed and washed three times with Tris-buffered
saline containing 0.1% Tween 20 and probed with the appropriate horseradish
peroxidase-conjugated secondary antibody for 1 h at room temperature. The
proteins were then visualized following incubation with enhanced chemilumines-
cence solution and exposure to X-ray film.
Cytokine detection. At various time points following PBS or SEB injection,
liver mononuclear cells were isolated as described above. The mononuclear cells
were adjusted to 2.5  106/ml in RPMI medium containing 10% fetal calf serum
and cultured in a 96-well flat-bottomed plate (200 l/well). The supernatants
were isolated 24 h later, and the levels of interleukin-2 (IL-2), gamma interferon
(IFN-), and tumor necrosis factor (TNF) were determined by using the methods
described by the manufacturer of the Quantikine M enzyme-linked immunosor-
bent assay (ELISA) kits (R&D Systems, Minneapolis, Minn.).
CFSE labeling and adoptive transfer. Splenocytes from CD44 WT or CD44
KO mice were labeled with carboxyl fluorescein succinimidyl ester (CFSE) as
described by the manufacturer (Molecular Probes, Eugene, Oreg.). Briefly, 107
cells were labeled with 5 M CSFE in PBS for 15 min at 37°C. The cells were
washed with PBS, resuspended, and incubated for an additional 30 min at 37°C.
The cells were washed twice with PBS and resuspended at 5  108/ml. CFSE-
labeled splenocytes (5 107) were adoptively transferred into CD44 WT mice by
intravenous injection.
RT-PCR. Total RNA was isolated from a single-cell suspension of splenocytes
by using an RNeasy Mini kit (QIAGEN, Valencia, Calif.). RNA concentration
was determined spectrophotometrically, and the integrity of each preparation
was verified by agarose gel electrophoresis. cDNA was synthesized by reverse
transcription (RT) of 50 ng of total RNA by using a SensiScript RT kit
(QIAGEN). All PCRs were prepared with MasterAmp PCR Premix F (Epicen-
tre Technologies, Madison, Wis.) according to the manufacturer’s recommenda-
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tions and Platinum Taq DNA polymerase (Invitrogen, Carlsbad, Calif.). The
following primers were used: -actin primers 5-AAGGCCAACCGTGAAAAG
ATGACC-3 and 5-ACCGCTCGTTGCCAATAGTGATGA-3 and Bax prim-
ers 5-GAGCAGCCGCCCCAGGATG-3 and 5-GGTGAGCGAGGCGGTG
AGGAC-3. A half-nested RT-PCR approach was used to amplify CD44
isoforms, as endogenous isoform expression is too low to be detected directly by
RT-PCR. An initial amplification step with primers referred to as CD44U and
CD44L, homologous to the 5 and 3 standard regions of the CD44 gene, was
used to amplify the CD44 standard form (CD44s) and all isoforms. The products
of this reaction were used as a template in a second reaction using a CD44
isoform-specific primer in conjunction with the appropriate CD44 standard re-
gion primer (CD44L and CD44U or CD44U and CD44L). The primers used to
detect CD44 isoform expression were CD44U (5-GCACCCCAGAAGGCTAC
ATTTT-3), CD44L (5-TTCTGCCCACACCTTCTCCTACTA-3), CD44v3L
(5-ATAAAATCTTCATCATCATCAAT-3), CD44v5U (5-GGACCCCGGAACC
ACAGC-3), CD44v7U (5-TTCGGCCCACAACAACCA-3), and CD44v7L (5-GA
TGTGAGATTGGGTCGAAGAAAT-3).
Microarray analysis of gene expression following SEB stimulation. Total
RNA was isolated from mononuclear cells harvested from the livers of CD44 WT
and CD44 KO mice 16 h following SEB stimulation by using an RNeasy Mini kit
(QIAGEN). Labeled cDNA probes were synthesized from the RNA samples by
using an Ampolabeling-LPR kit (SuperArray, Frederick, Md.). The labeled
cDNA probes were hybridized to individual GEArray Q series mouse apoptosis
array membranes overnight at 60°C with continuous agitation at 5 to 10 rpm. The
membranes were washed twice for 10 min at 60°C with a 2 SSC (1 SSC is 0.15
M NaCl plus 0.015 M sodium citrate)–1% sodium dodecyl sulfate solution and
twice for 10 min at 60°C with 0.1 SSC–0.5% sodium dodecyl sulfate. Nonspe-
cific binding was blocked by incubating the membranes with GEA blocking
solution (SuperArray, Frederick, Md.) for 40 min. The membranes were labeled
with alkaline phosphatase-conjugated streptavidin for 10 min. Excess alkaline
phosphatase-conjugated streptavidin was removed by washing the membranes
four times with buffer F (SuperArray) for 5 min and rinsing the membranes with
buffer G. Gene expression was detected with CDP-Star (Applied Biosystems)
chemiluminescent substrate and by exposing the membranes to X-ray film. The
data were analyzed by converting the X-ray image into a grayscale TIFF file and
using the ScanAlyze software program to convert the data into numerical data.
Finally, data analysis was performed by using the GEArray Analyzer data anal-
ysis software (SuperArray). Data were normalized by using housekeeping genes
including -actin, GAPDH (glyceraldehyde-3-phosphate dehydrogenase), cyclo-
philin A, and ribosomal protein L13a.
Statistical analysis. Analysis of variance and Student’s t test were used to
determine statistical significance, and a P value of 0.05 was considered to be
statistically significant.
RESULTS
SEB exposure leads to increased CD44 expression on liver
mononuclear cells. We examined the effect of in vivo SEB
exposure on the levels of CD44 expression in liver mononu-
clear cells. To this end, CD44 WT and CD44 KO mice were
injected with SEB and D-galactosamine. Twenty-four hours
posttreatment, mononuclear cells were isolated from the livers
of vehicle- or SEB-injected mice. The mononuclear cells were
then stained with FITC-labeled anti-CD3 MAbs, PE-labeled
anti-NK1.1 MAbs, and Cy-chrome-labeled anti-CD44 MAbs
(Fig. 1). The expression levels of the various molecules were
determined by using a flow cytometer. The results showed that
all populations of mononuclear cells from the CD44 WT mice,
including T cells, NK cells, and NKT cells, expressed CD44.
The mononuclear cells from naı¨ve mice contained populations
with low and high expression levels of CD44. Following expo-
sure to SEB, a majority of the cells expressed high levels of
CD44, which led to an overall increase in the mean fluores-
cence intensity. In contrast, the mononuclear cells from the
CD44 KO mice did not express CD44 (data not shown). To-
gether, these results suggest that exposure to SEB in vivo leads
to an increase in the expression of CD44 in T cells, NK cells,
and NKT cells found in the liver.
CD44 KO mice are susceptible to SEB-induced hepatocel-
lular damage. One of the characteristics of SEB-induced toxic
shock is liver injury. Therefore, we examined whether the de-
letion of CD44 had an effect on the susceptibility of C57BL/6
mice to SEB-induced hepatitis. To this end, CD44 WT and
CD44 KO mice were injected with SEB and D-galactosamine.
Hepatocellular damage was initially quantified by measuring
AST levels in plasma at 0, 24, 48, and 72 h following injection
of SEB and D-galactosamine (Fig. 2A). The results showed that
injection of SEB and D-galactosamine led to a slight increase in
the AST levels in the CD44 WT mice, peaking at 24 h following
injection. In contrast, injection of SEB and D-galactosamine
into CD44 KO mice led to a dramatic increase in AST levels
24 h after injection of SEB. The AST levels in both groups
diminished by 48 h postinjection. The AST levels in CD44 WT
or CD44 KO mice injected with D-galactosamine and PBS
ranged from 30 to 80 U/liter, similar to what was seen in mice
injected with PBS alone (data not shown), while AST levels in
CD44 KO mice were as high as 2,000 U/liter in the CD44 KO
mice 24 h following injection with D-galactosamine and SEB
(Fig. 2A), suggesting that D-galactosamine exposure alone was
not responsible for the induction of hepatitis in this model.
In addition, we examined SEB-induced liver injury by as-
sessing the level of apoptosis in livers from untreated and
SEB-treated mice. To this end, CD44 WT and KO mice were
injected with SEB and D-galactosamine. The livers were har-
vested 24 h following SEB and D-galactosamine injection, sec-
tioned, and stained for apoptosis by using the TUNEL method
FIG. 1. SEB exposure leads to increased CD44 expression on liver
mononuclear cells. CD44 WT mice were injected with SEB (20 g/
mouse) and D-galactosamine (20 mg/mouse). Twenty-four hours later,
the liver mononuclear cells were stained with FITC-conjugated anti-
CD3 MAbs, PE-conjugated anti-NK1.1 MAbs, and Cy-chrome-conju-
gated anti-CD44 MAbs. Next, CD3, NK1.1, or CD3 NK1.1
(NKT) cells were gated, and the level of CD44 expression on these
populations was determined by FACS analysis. The data are depicted
as mean fluorescence intensity (MFI). More than 1,000 events were
analyzed per gated population.
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(Fig. 2B). The level of apoptosis was quantified by determining
the number of TUNEL-positive hepatocytes in 12 random
fields taken from three individual mice per treatment group
(Fig. 2C). The results showed that there were no significant
levels of apoptotic cells in the PBS-exposed CD44 WT or
CD44 KO mice (data not shown). Following SEB exposure,
there was an increase in apoptotic hepatocytes in both the
CD44 WT and CD44 KO mice. However, the levels of apo-
ptosis were significantly higher in the SEB-exposed CD44 KO
mice than those in the SEB-exposed CD44 WT mice. To-
gether, these results suggested that CD44 KO mice are signif-
icantly more susceptible to SEB-induced hepatitis than CD44
WT mice and that this susceptibility correlates with increased
induction of apoptosis in the liver.
Adoptive transfer of splenocytes from CD44 KO mice leads
to increased SEB-induced AST levels in CD44 WT mice. In the
above-mentioned experiments, it was not clear whether the
increase in SEB-induced hepatitis was the result of a deficiency
of CD44 on lymphocytes or on hepatocytes. To address this,
splenocytes from CD44 WT or CD44 KO mice were adoptively
transferred into CD44 WT (Fig. 3A) or CD44 KO (Fig. 3B)
mice followed by administration of SEB and D-galactosamine,
and the induction of hepatitis was determined by measuring
AST levels in plasma. The results showed that adoptive trans-
fer of CD44 KO splenocytes into CD44 WT or CD44 KO mice
followed by exposure to SEB and D-galactosamine led to a
significant increase in AST levels compared to the levels of
AST from CD44 WT or CD44 KO mice injected with CD44
WT splenocytes. Together, these data suggested that the in-
creased SEB-induced hepatitis seen in CD44 KO mice was
FIG. 2. CD44 KO mice are more susceptible to SEB-induced hep-
atocellular damage mediated by induction of apoptosis. CD44 WT and
CD44 KO mice were injected with SEB (20 g/mouse) and D-galac-
tosamine (20 mg/mouse). Liver damage was assessed 24 to 72 h later by
measuring AST levels in plasma (A). The induction of apoptosis in the
liver following exposure to SEB was assessed by TUNEL staining of
fixed liver sections from SEB-treated CD44 WT and CD44 KO mice
(B). Examples of apoptotic cells are indicated with arrows. The level of
apoptosis in the liver was quantified by counting the number of
TUNEL-positive cells/field from 12 fields (C). The average  the
standard error of the mean (SEM) from three mice per treatment
group is depicted. Asterisks indicate statistically significant differences
compared to the CD44 WT controls (P  0.05).
FIG. 3. Adoptive transfer of splenocytes from CD44 KO mice leads
to increased SEB-induced hepatitis. Splenocytes from CD44 WT or
CD44 KO mice were adoptively transferred into CD44 WT (A) or
CD44 KO (B) mice. The mice were then injected with SEB (20 g/
mouse) and D-galactosamine (20 mg/mouse), and the induction of
hepatitis was determined by measuring AST levels 24 h later. PBS-
injected mice were used as controls for normal AST levels. Asterisks
indicate statistically significant differences compared to the CD44 WT
controls (P  0.05).
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due, at least in part, to a deficiency of CD44 on SEB-activated
lymphocytes.
Role of cytokines in SEB-induced hepatotoxicity in CD44
KO mice. TNF-	, IFN-, and IL-2 have been reported to play
a significant role in the induction of SEB-induced liver damage
(50); therefore, we examined whether the levels of these cyto-
kines were altered in CD44 KO mice following injection with
SEB and D-galactosamine compared to similarly treated CD44
WT mice (Fig. 4). Based on previous reports of the kinetics of
cytokine production following SEB exposure (15), liver mono-
nuclear cells were isolated at various time points (4, 8, and
16 h) following SEB and D-galactosamine injection. The cells
were cultured for an additional 24 h in vitro, after which the
supernatants were collected and tested for the presence of
TNF-	, IFN-, and IL-2 by ELISA. The results showed that
mononuclear cells from CD44 KO mice produced significantly
elevated levels of TNF-	 as early as 4 h following SEB expo-
sure compared to those of mononuclear cells from CD44 WT
mice. However, at 8 h, the level of detectable TNF-	 was
reduced, and no significant differences could be observed be-
tween the CD44 WT and CD44 KO mice. The level of IFN-
produced by the CD44 KO liver mononuclear cells was signif-
icantly elevated as early as 4 h following SEB exposure. The
levels peaked at 8 h and remained significantly higher 16 h
following SEB exposure compared to levels of IFN- produced
by CD44 WT liver mononuclear cells. No significant differ-
ences were seen in the levels of IL-2 production. Together,
these results demonstrate that SEB exposure leads to a rapid
increase and subsequent reduction in the production of TNF-	
and IFN-, consistent with the kinetics of cytokine production
following SEB exposure (15) and suggest that increased TNF-	
and IFN- production may play a significant role in the in-
creased sensitivity of CD44 KO mice to SEB-induced hepatitis.
Effect of SEB on liver mononuclear cell populations in CD44
WT and CD44 KO mice. Next, we examined the effect of SEB
exposure on the number and phenotype of liver mononuclear
cells in CD44 WT and CD44 KO mice. Injection of SEB and
D-galactosamine into CD44 WT mice led to an increase in the
total number of mononuclear cells compared to vehicle-
treated controls. This increase was first visualized by hematox-
ylin and eosin staining of liver sections (Fig. 5B) and then
further confirmed by direct enumeration of liver mononuclear
cells following isolation by Ficoll-Isopaque density gradient
centrifugation (Fig. 5A). After exposure to SEB and D-galac-
tosamine, the number of mononuclear cells in the CD44 WT
mice rose steadily in a time-dependent manner (Fig. 5A).
However, exposure of CD44 KO mice to SEB and D-galac-
tosamine led to a significantly greater increase in mononuclear
cells compared to the CD44 WT mice at all time points tested
(Fig. 5A). Phenotypic characterization of the liver mononu-
clear cells revealed a significant increase in CD3 cells, V8
cells, NK cells, and NKT cells in the CD44 WT mice (Table 1).
In comparison, the CD44 KO mice showed a greater increase
in almost all subpopulations of mononuclear cells in both per-
centage and absolute numbers following SEB injection (Table
1).
SEB-reactive cells from CD44 KO mice undergo increased
numbers of cell divisions. The elevated number of mononu-
clear cells found in the livers of CD44 KO mice following SEB
injection suggested the possibility that the absence of CD44
leads to increased proliferation and/or decreased susceptibility
to SEB-induced apoptosis. To study the number of cell divi-
sions that the SEB-activated CD44 or CD44
 lymphocytes
would undergo, we adoptively transferred CFSE-labeled CD44
WT or CD44 KO splenocytes into CD44 WT mice, injected
them with SEB and D-galactosamine (as described in Materials
and Methods), and enumerated CFSE-positive cells in the liver
24 h later. These data revealed that the proportion of CFSE-
positive liver-infiltrating CD44 KO mononuclear cells that un-
derwent six or more cell divisions was significantly higher than
that of CFSE-positive cells from CD44 WT mice (Fig. 6).
These data suggested that the increased numbers of mononu-
clear cells in CD44 KO livers as seen earlier (Fig. 5) was likely
FIG. 4. Increased production of TNF-	 and IFN- from SEB-stim-
ulated CD44 KO liver mononuclear cells. CD44 KO mice and CD44
WT mice were injected with SEB as described in the legend of Fig. 1.
Liver mononuclear cells were isolated at various time points (4, 8, and
16 h) following SEB injection and cultured in triplicate for an addi-
tional 24 h in vitro. The supernatants were tested for the presence of
TNF-	, IFN-, and IL-2 by ELISA. Vertical bars represent the mean 
SEM. Asterisks indicate statistically significant differences compared to
CD44 WT liver mononuclear cells (P  0.05).
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due to an increased number of cell divisions in SEB-reactive
cells.
SEB-reactive cells from CD44 KO mice are more resistant
to apoptosis. Upon SEB activation, the T cells rapidly undergo
apoptosis. Previous studies from our laboratory showed that
CD44 plays a critical role in AICD (35); therefore, we inves-
tigated whether this would impact the number of liver mono-
nuclear cells found following SEB injection. To this end, CD44
WT and CD44 KO mice were injected with SEB and D-galac-
tosamine, and 24 h later, the liver mononuclear cells were
isolated and cultured in vitro for 24 h. The level of apoptosis
was determined by using TUNEL (Fig. 7A). The results
showed that following injection of SEB and D-galactosamine,
there was significant induction of apoptosis in the mononuclear
cells isolated from CD44 WT mice. In contrast, mononuclear
cells from CD44 KO mice showed significantly lower levels of
apoptosis 24 h following SEB and D-galactosamine injection
than mononuclear cells from CD44 WT mice. Similar results
were seen when the annexin-PI method for apoptosis detection
was used (data not shown). In addition, we examined the levels
of cleaved-active caspase-3 in mononuclear cells isolated from
untreated and SEB-treated CD44 WT and CD44 KO mice and
found that following exposure to SEB, there was an increase in
the levels of cleaved-active caspase-3 in CD44 WT mice (Fig.
7B). In contrast, the levels of cleaved-active caspase-3 were
significantly lower in mononuclear cells from SEB-treated
CD44 KO mice. Together, these results suggested that liver
mononuclear cells from CD44 KO mice are more resistant to
SEB-induced apoptosis.
Microarray analysis of gene expression in liver mononu-
clear cells following stimulation with SEB in vivo. Next, we
screened for alterations in the expression of genes involved in
apoptosis in liver mononuclear cells following exposure to SEB
and D-galactosamine with cDNA array analysis. Of the 96
genes screened, the expression of 25 genes was significantly
(greater than twofold) altered in the liver mononuclear cells
FIG. 5. Quantification of liver mononuclear cell populations fol-
lowing SEB injection. The presence of mononuclear cells was visual-
ized by staining with hematoxylin and eosin (A). CD44 WT and CD44
KO mice were injected with SEB and D-galactosamine as described in
the legend of Fig. 1. CD44 WT and CD44 KO mice were injected with
PBS or SEB as described in the legend of Fig. 1. Twenty-four hours
later, the livers were harvested, fixed, and sectioned. Arrows indicate
mononuclear cell populations. To quantify liver mononuclear cells,
cells were isolated 0 to 72 h following SEB exposure and quantified by
trypan blue dye exclusion and expressed as the absolute number of
cells per liver (B). Asterisks indicate statistically significant differences
compared to the CD44 WT controls (P  0.05).
FIG. 6. Adoptive transfer of CFSE-labeled CD44 WT or CD44 KO
splenocytes into CD44 WT mice. Splenocytes from CD44 WT or CD44
KO mice were stained with CFSE and then adoptively transferred into
CD44 WT mice. The mice were then injected with SEB plus D-galac-
tosamine as described in the text. Twenty-four hours later, the liver
mononuclear cells were harvested, and the number of cell divisions was
determined by FACS analysis. Each cell division is indicated by brack-
ets. The proportion of CD44 WT cells to CD44 KO cells in each cell
division is depicted in panel B. The results are representative data of
experimental groups containing three mice. The experiment has been
repeated three times with similar results.
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from the CD44 KO mice. The expression of 15 genes was
reduced while the expression of 10 genes was increased in the
CD44 KO liver mononuclear cells (Table 2). Included in the
group of genes expressed at lower levels were the proapoptotic
Apaf-1, Bak, Bax, Bid, HrK, CRADD, caspase-1, and caspase-8
genes. In addition, the expression of a number of antiapoptotic
genes, including TANK, OX40, OX40L, TRAF2, and TRAF3,
was upregulated. Taken together, the results from the cDNA
analysis further supported a role of CD44 in regulating the
induction of apoptosis in SEB-activated liver mononuclear
cells. More specifically, the data suggested that in the absence
of CD44, the expression of a number of proapoptotic genes is
decreased while the expression of a number of antiapoptotic
molecules is increased.
Liver-infiltrating mononuclear cells from CD44 KO mice
express lower levels of Bax following SEB stimulation in vivo.
Bcl-2-related proteins play an important role in the induction
of apoptosis following SEB stimulation (22). Based on the
results from our cDNA array analysis, we further examined the
effect of CD44 deficiency on the levels of Bax (Fig. 8). To this
end, CD44 WT and CD44 KO mice were treated with SEB and
D-galactosamine as described above. Liver-infiltrating mono-
nuclear cells were isolated 24 h following SEB injection, and
Bax mRNA levels were determined by RT-PCR (Fig. 8A). The
results from several experiments showed that there was a sig-
nificant increase in the level of Bax mRNA in the infiltrating
mononuclear cells from SEB-injected CD44 WT mice com-
pared to that of vehicle-treated CD44 WT mice. In contrast,
the level of Bax mRNA in the liver mononuclear cells from
CD44 KO mice was not significantly altered following SEB
stimulation. More specifically, following exposure to SEB, the
expression of Bax mRNA was increased by 42%  3% in the
CD44 WT mice and only by 9%  5% in CD44 KO mice.
Together, these data validated the results from cDNA array
analysis and further suggested that the observed resistance of
CD44 KO liver-infiltrating mononuclear cells to apoptosis may
be due, at least in part, to a defect in the induction of Bax
following activation with SEB in vivo.
Anti-CD44 MAbs enhance SEB-induced hepatitis in vivo. In
a previous report, Mustafa et al. demonstrated that in vivo
treatment with anti-CD44 MAbs leads to reduced cell surface
expression of CD44 on splenocytes in vivo (39). Therefore, in
the present study, we examined whether treatment with anti-
CD44 antibodies and subsequent reduction in CD44 expres-
sion would have any effect on SEB-induced hepatitis. To this
end, CD44 WT mice were treated with SEB and D-galac-
tosamine plus isotype control antibodies or SEB and D-galac-
tosamine plus anti-CD44 MAbs (IM7). The level of liver dam-
age was determined 24 h later by measuring AST levels in
plasma (Fig. 9A). The results showed that treatment with anti-
FIG. 7. CD44 KO liver mononuclear cells are resistant to SEB-induced apoptosis. CD44 WT and CD44 KO mice were injected with SEB and
D-galactosamine as described in the legend of Fig. 1. Twenty-four hours later, mononuclear cells were isolated from the liver and assayed for the
presence of apoptotic cells. Apoptosis in liver mononuclear cells was assayed by using the TUNEL method (A). The level of caspase-3 cleavage
was determined by Western blot analysis and depicted as a ratio of caspase-3 levels to -actin levels (B).
TABLE 1. Effects of SEB on liver mononuclear cell populations in vivo
Treatment
Cellularitya
(cells [105]/
liver)
Liver mononuclear cell populationsb
V8 CD3

NK1.1

CD3

NK1.1
CD3
NK1.1
CD44 WT  PBS 3.6  0.4 14.7 (0.53) 25.5 (0.92) 2.1 (0.08) 5.0 (0.18)
CD44 WT  SEB 7.5  0.4 35.3 (2.65) 36.2 (2.72) 11.1 (0.83) 3.3 (0.25)
CD44 KO  PBS 2.5  0.05 21.5 (0.54) 24.5 (0.61) 1.8 (0.05) 4.3 (0.11)
CD44 KO  SEB 14.4  0.1 53.26 (7.67) 37.6 (5.41) 12.7 (1.83) 16.0 (2.3)
a D-galactosamine-sensitized mice were treated with SEB or the vehicle. Twenty-four hours later, the liver mononuclear cells were isolated, and the total cell number
was determined. Data represent means  SEM obtained from three mice.
b Liver mononuclear cell subsets were determined by using flow cytometry. The data represent the percentage of V8 cells, CD3 NK1.1
 cells, CD3
 NK1.1
cells, and CD3 NK1.1 cells in the livers obtained from three mice. The numbers in parentheses represent the mean total cellularity. (105) of each cell population
found in the liver.
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CD44 MAbs led to a significant increase in the AST levels
compared to those of mice injected with SEB plus isotype
control antibodies. In addition, we determined whether treat-
ment with anti-CD44 MAbs had an effect on the level of CD44
expression on liver mononuclear cells (Fig. 9B). To this end,
liver mononuclear cells from vehicle-treated and SEB-treated
mice which received either anti-CD44 MAbs or isotype control
antibodies were stained for the expression of CD44 and ana-
lyzed by fluorescence-activated cell sorter (FACS). The results
demonstrated that treatment with SEB led to a significant
increase in CD44 expression compared to the vehicle-treated
mice. Interestingly, treatment of SEB-exposed mice with anti-
CD44 MAbs led to a significant reduction in CD44 expression.
In addition, the percentage and number of CD3-positive and
NK1.1-positive cells were not affected by anti-CD44 MAb
treatment (data not shown). Together, the data from this set of
experiments suggested that administration of anti-CD44 MAbs
into CD44 WT mice leads to increased susceptibility to SEB-
FIG. 8. Expression of Bax by liver mononuclear cells following
stimulation with SEB in vivo. CD44 WT and CD44 KO mice were
injected with SEB and D-galactosamine as described in the legend of
Fig. 1. Twenty-four hours later, the liver mononuclear cells were iso-
lated and whole cell extracts were prepared. Expression of Bax and
-actin was analyzed by RT-PCR analysis.
FIG. 9. Administration of anti-CD44 MAbs enhances SEB-induced
hepatitis in vivo. Groups of five mice were injected with SEB (20
g/mouse) and D-galactosamine (20 mg/mouse). In addition, groups of
mice received 100 g of anti-CD44 MAb (IM7) or isotype control
antibody (A). Liver damage was determined 24 h later by measuring
levels of AST in plasma. Vertical bars represent the mean level of AST
(units/liter [U/L])  SEM. The level of CD44 expression on liver
mononuclear cells following anti-CD44 treatment was determined by
FACS analysis (B). Asterisks indicate statistically significant differ-
ences compared to the isotype controls (P  0.05).
TABLE 2. cDNA array analysis of apoptotic gene expression in liver mononuclear cells from CD44 KO and
CD44 WT mice following SEB exposurea
Gene name Description or function GenBank accession no. Change (Fold)vs CD44 WTb
Apaf-I Apoptotic protease activating factor-1 NM_009684 
29.1
April APRIL mRNA AF294825 
11.3
Bad Displaces Bax and promotes apoptosis L37296 
3.0
Bak Bcl-2 antagonist NM_007523 
6.0
Bax Bcl-2-associated X protein L22472 
33.3
Bcl-w Bcl-2-like 2 AF030769 
3.7
Bid BH3-interacting domain, death agonist NM_007544 
5.6
HrK BH3-interacting domain, apoptosis agonist D83698 
77.5
IAP1 Inhibitor of apoptosis protein 1 U88908 
3.3
IAP2 Inhibitor of apoptosis protein 2 U88909 
4.6
X-linked IAP X-linked inhibitor of apoptosis U88990 
22.2
caspase-1 IL-1 convertase L03799 
5.0
caspase-8 Caspase-8 AF067834 
4.5
CRADD Death adaptor molecule AJ224738 
2.8
DAP kinase Death-associated kinase 2 AF052942 
4.7
caspase-12 Caspase-12 NM_009808 2.3
caspase-2 Caspase-2 D28492 2.2
TANK TRAF family member-associated NF-B activator U51907 3.3
OX40 OX40 Z21674 2.5
OX40L OX40 ligand U12763 2.3
Fas Fas antigen NM_007987 2.5
FasL Fas ligand U06948 2.2
CD40L CD40 ligand X65453 3.1
TRAF2 TNF receptor-associated factor 2 L35303 4.7
TRAF3 TRAF-related protein L08752 5.7
a Summary of gene expression that was found to be increased or decreased in mononuclear cell isolated from the liver of CD44 KO mice following injection with
SEB compared to the gene expression in mononuclear cells isolated from the liver of CD44 WT mice following injection with SEB.
b Change (fold) represents the change in gene expression following normalization with -actin gene expression.
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induced hepatitis by reduction of CD44 expression on liver
mononuclear cells.
Alteration of CD44v7 variant isoform expression following
SEB exposure in vivo. To determine whether SEB treatment
led to the differential regulation of CD44 variant isoform ex-
pression, liver mononuclear cells from CD44 WT mice injected
with SEB and D-galactosamine or PBS were harvested after
24 h and analyzed for the expression of various CD44 isoforms.
The results showed that treatment with SEB in vivo led to the
increased expression of the CD44 standard form (CD44s) (Fig.
10B, panel 1) and the variable expression of a number of CD44
variant isoforms (Fig. 10B). Here, the presence of multiple
bands is expected due to the combinatorial nature of CD44
isoform expression. Most notable was the dramatic induction
of isoforms containing alternatively spliced exon 7 (v7). Am-
plification using a v7 reverse primer and CD44 conserved re-
gion forward primer (Fig. 10B, panel 4) yielded two products in
PBS-treated samples, suggesting that two CD44 isoforms con-
taining the v7 gene products were present. In contrast, in
SEB-exposed mice, we observed four bands representing four
individual CD44 isoforms containing the v7 gene product, sug-
gesting that stimulation with SEB leads to the expression of at
least two additional CD44 isoforms containing the v7 exon
gene products. More specifically, since we observed four indi-
vidual bands, these results suggest that four unique combina-
tions of CD44 (v1 to v7) isoforms are present following SEB
stimulation, all of which contain the v7 gene product. Similarly,
amplification with a v7 forward primer and CD44 conserved
region reverse primer yielded only one band in the PBS-
treated sample (Fig. 10B, panel 5). In contrast, two products
were generated in the sample from the SEB-treated mice,
suggesting that SEB stimulation of liver mononuclear cells
results in at least one additional CD44 isoform containing the
v7 exon gene product in combination with at least one other
CD44v8 to CD44v10 exon gene product. When the expression
of CD44 isoforms containing the v3 and v5 exons was analyzed,
we noted that exposure to SEB had no significant effect on
their expression (Fig. 10B, panels 2 and 3). Together, these
data suggested that exposure to SEB leads to differential reg-
ulation of CD44 isoforms containing the v7 exon.
Deletion of CD44v7 leads to increased susceptibility to SEB-
induced hepatitis in vivo. After we determined that exposure
to SEB affected the expression of CD44 isoforms containing
the v7 exon, we examined whether expression of CD44v7
played a role in the regulation of SEB-induced hepatitis. To
this end, CD44 WT and CD44v7 KO mice were injected with
SEB and D-galactosamine. Hepatocellular damage was quan-
tified by measuring AST levels in plasma at 0, 24, 48, and 72 h
following injection of SEB (Fig. 10A). The results showed that
injection of SEB led to a slight increase in the AST levels in the
CD44 WT mice, peaking at 24 h following injection. In con-
trast, injection of SEB and D-galactosamine into CD44v7 KO
mice led to a dramatic increase in AST levels 24 h after injec-
tion of SEB. The AST levels in both groups diminished by 48 h
postinjection.
DISCUSSION
In the present study, we demonstrated that following expo-
sure to SEB, mice deficient in CD44 have significantly elevated
levels of liver damage compared to levels of liver damage in
wild-type mice. This increase resulted from enhanced produc-
tion of cytokines known to be associated with SEB-induced
shock. More specifically, TNF-	 and IFN- levels were signif-
icantly elevated in CD44 KO mice following SEB exposure.
Evaluation of the mechanism of CD44 involvement in SEB-
induced hepatotoxicity revealed that the absence of CD44 ren-
dered liver mononuclear cells resistant to the induction of
apoptosis, possibly due to an inhibition in the expression of a
number of proapoptotic molecules, including Bax. This possi-
ble role of CD44 in activated cells is further supported by
previous work from our laboratory which demonstrated that
CD44 KO mice are more susceptible to concanavalin A-in-
duced hepatitis and that CD44 is important in activation-in-
duced cell death following stimulation with conventional anti-
gens and superantigens (35), and the possible role of Bax is
supported by a previous report showing that cross-linking of
CD44 on dexamethasone-treated thymic lymphomas leads to
upregulation of Bax (19). In the present study, we further
demonstrate that CD44v7 may play a critical role in regulating
SEB-induced liver injury. Together, our studies suggest that in
wild-type mice, SEB triggers CD44 expression on resident lym-
FIG. 10. The role of CD44v7 in SEB-induced activation and induc-
tion of hepatitis. (A) Deletion of CD44v7 leads to increased suscepti-
bility to SEB-induced hepatitis. Groups of five CD44 WT and CD44v7
KO mice were injected with SEB (20 g/mouse) and D-galactosamine
(20 mg/mouse). Liver damage was determined 0 to 72 h later by
measuring levels of AST in plasma. Plots represent the mean level of
AST (units/liter [U/L])  SEM. The asterisk indicates a statistically
significant difference compared to the CD44 WT controls. (B) RT-
PCR-based characterization of CD44 isoform expression in SEB-acti-
vated liver mononuclear cells. RNA isolated from splenocytes of PBS-
treated and SEB-treated mice was subjected to RT-PCR analysis using
the PCR strategy depicted above. PCR products were resolved on
1.2% agarose gels.
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phocytes in the liver, whose activation also leads to production
of cytokines, capable of mediating liver injury. However, sig-
naling through CD44 triggers rapid apoptosis in SEB-activated
cells, thereby limiting the liver injury. Thus, dysregulation in
CD44 expression in liver mononuclear cells may exacerbate
SEB-induced hepatic injury.
SEB interacts with major histocompatibility complex-en-
coded molecules and activates primarily V8 T cells (10). In
the present study, we demonstrated that following SEB stim-
ulation in vivo, there was a significant increase in the number
of CD3 and V8 cells in the liver. The liver contains a
unique distribution of lymphocytes highly enriched for NK and
NKT cells (4). NK cells play an important role in the induction
of hepatitis following concanavalin A exposure or infection
with adenovirus vectors (30, 51). More specifically, it is be-
lieved that NK cells act by producing cytokines such as IFN-,
which leads to the recruitment and accumulation of T cells in
the liver (47). Although the liver is known to be rich in NKT
cells (4), the exact role of these cells in the immune response
in the liver is largely unknown. However, Takeda et al. dem-
onstrated that Fas ligand expression on liver NKT cells played
a critical role in the pathogenesis of concanavalin A-induced
hepatitis (49). In the present study, we demonstrated that the
number and percentage of NK and NKT cells was significantly
elevated in the liver of CD44 WT mice following exposure to
SEB, suggesting a possible role of these cells in SEB-induced
toxic shock. Furthermore, since most NKT cells express V8.2
(25), it is possible that NKT cells can be directly activated by
SEB. Interestingly, the number of NKT cells was significantly
higher in CD44 KO mice following SEB exposure than in
similarly treated CD44 WT mice. In addition, following stim-
ulation of CD44 WT mice with SEB, we noted a significant
increase in the expression of CD44 on NKT cells, suggesting a
possible role of CD44 in NKT cell response to SEB.
SEB has been used to examine a number of processes im-
portant for the regulation of the immune system, including
cytokine production, T-cell anergy, and AICD (18, 38, 40).
Following immune activation, there is significant accumulation
of apoptotic lymphocytes in the liver. Although there is some
controversy as to whether the liver acts as a lymphocyte “grave-
yard” where dead or dying cells accumulate or as a lymphocyte
“killing field” where activated cells receive signals to undergo
apoptosis, considerable evidence suggests that activated cells
can directly undergo AICD in the liver (5). In the present
study, we used SEB to further explore the possible role of
CD44 in regulating lymphocyte apoptosis in the liver. Previous
reports from our laboratory demonstrated that the expression
of CD44 on activated lymphocytes plays an important role in
their interactions with endothelial cells (36, 41). Interestingly,
the regulation of activated lymphocytes in the liver is postu-
lated to take place through interactions with a number of cells
including Kupffer cells and sinusoidal endothelial cells (LSEC)
(26). Therefore, we speculate that interactions between acti-
vated lymphocytes and activated LSEC or Kupffer cells leads
to the induction of apoptosis in the activated lymphocytes and
that this signaling is either directly or indirectly regulated by
CD44 expression. This possibility is further supported by the
fact that LSEC have been shown to bind and express the CD44
ligand hyaluronic acid (28, 57).
The standard form of CD44, designated CD44s, is the most
common form and has a size of 85 to 95 kDa (17). In addition
to CD44s, a number of larger CD44 isoforms, ranging in size
from 80 to 250 kDa, develop due to alternative splicing of
variant exons (52). It has been suggested that expression of
specific isoforms may play a role in the regulation of the im-
mune response as well as in the development of autoimmune
disorders. In the present study, we demonstrate that exposure
to SEB leads to increased expression of CD44 isoforms con-
taining the v7 exon and that deletion of the CD44v7 exon
leaves mice more susceptible to SEB-induced hepatitis. To-
gether, these results suggest an important role of CD44v7 in
the regulation of the immune response following exposure to
the superantigen SEB. In contrast, studies examining the ef-
fects of TNBS on the induction of colitis using CD44v7 knock-
out mice clearly demonstrated that expression of CD44 variant
isoforms containing the v7 exon gene product played a role in
protecting lamina propria mononuclear cells from the induc-
tion of apoptosis (55). These apparent discrepancies can pos-
sibly be explained by the fact that these antigenic systems
activate distinct components of the immune system, and fur-
thermore, the pathogenesis in these models may involve dif-
ferent mechanisms. For example, TNBS-induced colitis is be-
lieved to be mediated by Th1 cells (54). In contrast, SEB is a
superantigen that activates a large proportion of T lympho-
cytes bearing specific V regions of the T-cell receptor as well
as macrophages (10). However, SEB-induced liver injury may
result from initial activation of Kupffer cells and subsequent
triggering of NK and NKT cells (7, 43, 55). Thus, signaling
through CD44 in these different effector cells may play differ-
ent or opposite roles. To date, little is known about the role of
CD44 isoforms in Kupffer, NK, and NKT cells. Also, there
could be differences in the intestinal and hepatic microenvi-
ronment in terms of the levels of CD44 receptor or the CD44
ligand expression.
To better understand the mechanism of CD44 involvement
in the induction of apoptosis in liver mononuclear cells, we
used cDNA array analysis. We observed that following stimu-
lation with SEB in vivo, there was a significant reduction in the
expression of a number of proapoptotic molecules and a sig-
nificant increase in the expression of a number of antiapoptotic
molecules in the mononuclear cells isolated from the livers of
CD44 KO mice compared to that of similarly treated CD44
WT mice. Of particular interest was the expression of Bax. We
demonstrated that the level of Bax mRNA in CD44 WT mice
was significantly elevated following stimulation with SEB. In
contrast, stimulation of liver mononuclear cells from CD44 KO
mice failed to cause significant upregulation of Bax. In addi-
tion, we demonstrated that the levels of caspase-8 and Bid
following stimulation with SEB were significantly lower in
CD44 KO mice than in SEB-treated CD44 WT mice.
Caspase-8 is believed to function primarily in the death recep-
tor pathway, whereas Bax plays an important role in the mito-
chondrial pathway (33), suggesting that CD44 may play a role
in both pathways. Bid serves as an important mediator of cross
talk between the death receptor and mitochondrial pathways
(29, 31). Since Bid is significantly reduced in SEB-stimulated
liver mononuclear cells from CD44 KO mice, it is possible that
signaling through CD44 directly leads to the activation of
death receptor molecules such as caspase-8 and the eventual
participation of the mitochondrial pathway through the in-
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volvement of molecules such as Bid, Bax, and HrK. The im-
portance of CD44 in the regulation of Bax is further supported
by other reports that demonstrated that the cross-linking of
CD44 led to upregulation of Bax expression in dexametha-
sone-treated thymic lymphomas (19). The role of CD44 sig-
naling in caspase-8 activation was shown in a study that exam-
ined the biological activity of a hyaluronan-binding peptide
that binds hyaluronan in a fashion similar to that of CD44. In
this study, it was shown that treatment with the peptide led to
increased expression of caspase-8 and the eventual induction
of apoptosis in a human breast cancer cell line (56).
Mice are relatively resistant to the effects of SEB and there-
fore require prior sensitization with D-galactosamine or endo-
toxins such as lipopolysaccharide. In contrast, humans are
highly sensitive to SEB, and exposure to SEB can lead to the
rapid onset of clinical symptoms. SEB is often associated with
food poisoning. However, SEB was weaponized by the United
States in the 1960s and, when inhaled, leads to rapid incapac-
itation (32). Symptoms include fever, respiratory distress,
headache, and in severe cases multiorgan failure, which are
thought to result from the release of large amounts of cyto-
kines such as IFN- and TNF-	 (34). Treatment of SEB-
induced toxic shock consists primarily of supportive therapy,
and there are currently no available vaccines for preventing
SEB-induced toxicities (34). Therefore, developing a better
understanding of the mechanism of SEB-induced toxicities
may lead to significantly enhanced specific treatments. In the
present study, we described a role for CD44 in the regulation
of the immune response following SEB exposure and we dem-
onstrated that treatment with anti-CD44 MAbs, which has
been shown to reduce cell surface expression of CD44 as
shown by others (39, 46), leads to exacerbated toxicity. To-
gether, these results suggest that alterations in CD44 expres-
sion or signaling may significantly alter the level of SEB-in-
duced toxicity and that CD44 expression may play an
important role in the regulation of the immune response in the
liver.
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